148 related articles for article (PubMed ID: 21575000)
1. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
2. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.
Dysart JS; Patterson MS
Photochem Photobiol Sci; 2006 Jan; 5(1):73-81. PubMed ID: 16395430
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
4. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
5. Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation.
Gillies R; Kollias N; Hasan T; Diddens H
J Photochem Photobiol B; 1996 Mar; 33(1):87-90. PubMed ID: 8786464
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
7. In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.
Casas A; Di Venosa G; Batlle A; Fukuda H
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):931-7. PubMed ID: 12699253
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
9. Intracellular localization and concentration as well as photodynamic effects of benzoporphyrin derivative monoacid ring A in four types of rodent tumor cells.
Osaki T; Takagi S; Hoshino Y; Okumura M; Fujinaga T
Cancer Lett; 2006 Nov; 243(2):281-92. PubMed ID: 16412570
[TBL] [Abstract][Full Text] [Related]
10. Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas.
Cincotta L; Szeto D; Lampros E; Hasan T; Cincotta AH
Photochem Photobiol; 1996 Feb; 63(2):229-37. PubMed ID: 8657737
[TBL] [Abstract][Full Text] [Related]
11. Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA).
Aveline B; Hasan T; Redmond RW
Photochem Photobiol; 1994 Mar; 59(3):328-35. PubMed ID: 8016212
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
13. Application of long-circulating liposomes to cancer photodynamic therapy.
Oku N; Saito N; Namba Y; Tsukada H; Dolphin D; Okada S
Biol Pharm Bull; 1997 Jun; 20(6):670-3. PubMed ID: 9212988
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.
Momma T; Hamblin MR; Wu HC; Hasan T
Cancer Res; 1998 Dec; 58(23):5425-31. PubMed ID: 9850075
[TBL] [Abstract][Full Text] [Related]
15. Differences between cytotoxicity in photodynamic therapy using a pulsed laser and a continuous wave laser: study of oxygen consumption and photobleaching.
Kawauchi S; Morimoto Y; Sato S; Arai T; Seguchi K; Asanuma H; Kikuchi M
Lasers Med Sci; 2004; 18(4):179-83. PubMed ID: 15042420
[TBL] [Abstract][Full Text] [Related]
16. Targeting activated lymphocytes with photodynamic therapy: susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization.
Obochi MO; Canaan AJ; Jain AK; Richter AM; Levy JG
Photochem Photobiol; 1995 Jul; 62(1):169-75. PubMed ID: 7638262
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
18. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy.
Lin GC; Tsoukas ML; Lee MS; González S; Vibhagool C; Anderson RR; Kollias N
Photochem Photobiol; 1998 Oct; 68(4):575-83. PubMed ID: 9796441
[TBL] [Abstract][Full Text] [Related]
19. BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells.
Runnels JM; Chen N; Ortel B; Kato D; Hasan T
Br J Cancer; 1999 Jun; 80(7):946-53. PubMed ID: 10362101
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells.
King DE; Jiang H; Simkin GO; Obochi MO; Levy JG; Hunt DW
Scand J Immunol; 1999 Feb; 49(2):184-92. PubMed ID: 10075023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
